2 unknown, 1 completed, 1 withdrawn. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Completed 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow iron isomaltoside 1000: new trials by email Literature Review of iron isomaltoside 1000 trials Research Report on iron isomaltoside 1000
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma Iron Isomaltoside 1000, Polysaccharide Iron Complex Pill, Intensity-modulated radiotherapy - Nasopharyngeal Carcinoma, Iron-deficiency | Phase 2 | Unknown | Sun Yat-sen University | 120 | 2023-05-05 | 2023-06-22 |
| Intravenous Iron Infusion on Chemotherapy-induced Anemia iron (isomaltoside), Dried Ferrous Sulfate - Colon Cancer, Chemotherapeutic-Induced Anemia | Phase 2 | Unknown | Korea University Guro Hospital | 80 | 2023-04-20 | 2022-03-29 |
| Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients Iron Isomaltoside 1000, Placebo: NaCl 0,9% - Heart Transplant Recipients | Phase 2 / Phase 3 | Completed | Oslo University Hospital | 102 | 2018-04-25 | 2021-05-25 |
| IV Iron Treatment of Restless Legs Syndrome Iron isomaltoside 1000, Sodium Chloride 0.9% - Restless Legs Syndrome | Phase 2 | Withdrawn | Pharmacosmos A/S | 2015-01-01 | 2015-06-30 |
Anemia (1) · Anemia, Iron-Deficiency (1) · Colonic Neoplasms (1) · Iron Deficiencies (1) · Nasopharyngeal Carcinoma (1) · Restless Legs Syndrome (1)
Korea University Guro Hospital (1) · Oslo University Hospital (1) · Pharmacosmos A/S (1) · Sun Yat-sen University (1)
China (1) · Norway (1)
Lars Gullestad, MD, PhD (1) · Richard Allen, Assoc Prof (1) · Shan Shan Guo, Dr (1)